AnalystsJames CondulisJames Condulis's Stock Forecasts
AnalystsJames Condulis
Sectors:
Industries:
Analyst Ranking
Top 39%
#2023 out of 5156 analysts
Average Return
+9.91%
Win Rate
63%5 out of 8
Risk vs Reward
Poor
Good
James Condulis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Newamsterdam Pharma Co NvNAMS | +55.22% | $21.84 | $33.90 | 2025-06-09 - 2025-12-18 | Strong Buy |
Cytokinetics IncCYTK | +32.85% | $46.82 | $62.20 | 2025-01-21 - 2025-12-18 | Strong Buy |
Cytokinetics IncCYTK | +25.35% | $49.62 | $62.20 | 2025-09-01 - 2025-12-18 | Strong Buy |
Soleno Therapeutics IncSLNO | +7.54% | $44.99 | $48.38 | 2025-03-04 - 2025-12-18 | Strong Buy |
Aardvark Therapeutics IncAARD | +0.07% | $13.68 | $13.69 | 2025-09-28 - 2025-12-18 | Strong Buy |
James Condulis Analyst Color
Get additional color on James Condulis's coverage of popular stocks
James Condulis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $50.00 | +47.49% | Maintains | 3 days ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $10.00 | +173.22% | Maintains | 14 days ago |
Aardvark Therapeutics IncAARD | 1 | Strong Buy | $24.00 | +75.31% | Initiates Coverage On | 3 months ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $96.00 | +54.34% | Maintains | 4 months ago |
Soleno Therapeutics IncSLNO | 2 | Strong Buy | $108.00 | +123.23% | Maintains | 9 months ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $30.00 | +41.84% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.